Pharmacology

The body's ability to break down medicines may be closely related to exposure to sunlight, according to a study from the Swedish medical university Karolinska Institutet. This could mean drug metabolism is influenced by seasons and might explain i ...

Article - News Staff - Mar 9 2011 - 2:11pm

Actos May Help Prevent Diabetes- But You Probably Don't Want It (Yet)

The big news in the diabetes world this week is a new article in the New England Journal of Medicine (link here) about how Actos (scientific name: pioglitazone) can help prevent the development of diabetes in folks with prediabetes. The American Diabetes ...

Article - Ryan Luce - Mar 27 2011 - 5:42pm

Spice Up Your Love Life- Literally

Ginseng and saffron are sexual performance boosters, according to a new scientific review of natural aphrodisiacs, but while the more obscure Spanish fly and Bufo toad are purported to be sexually enhancing, they produced the opposite result and can even b ...

Article - News Staff - Mar 28 2011 - 12:56pm

Will Taking Lipitor Increase Your Chances of Diabetes? Yes. Should You Stop Taking It? Probably Not.

Research was published in the Journal of the American College of Cardiology today with analysis of three different clinical trials that looked at Lipitor (scientific name: atorvastatin). The authors found new evidence that taking Lipitor slightly increase ...

Blog Post - Ryan Luce - Mar 30 2011 - 12:44pm

Antidepressants Linked To Thicker Arteries

A study of twin veterans has linked antidepressant use to thicker arteries and therefore possibly increased risk of heart disease and stroke, according to data presented last week at the American College of Cardiology meeting in New Orleans. The study incl ...

Article - News Staff - Apr 13 2011 - 11:57am

Orphan Drug Status For LPA1 Antagonist AM152 For Treatment Of Idiopathic Pulmonary Fibrosis

Amira Pharmaceuticals, Inc. announced today that AM152, the company's lead LPA1 antagonist, has been granted an orphan drug designation by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis. Commonly referred to ...

Article - News Staff - Apr 22 2011 - 10:07am

Clinical Phase IIb Study Of ATH008 In Hand-Foot Syndrome (Palmar-Plantar Erythrodysesthesia Syndrome)

ADVANCELL has initiated a phase IIb clinical study of the Company's ATH008, for the treatment of the palmar-plantar erythrodysesthesia syndrome, also known as hand-foot syndrome, a painful side-effect of certain chemotherapies such as capecitabine an ...

Article - News Staff - Apr 22 2011 - 6:27pm

Excessive Doses Of Thyroid Drugs Linked To Increased Risk Of Fractures In Elderly

Too many older adults are taking "excessive" doses of drugs for thyroid problems and that has been linked to an increased risk of fractures, according to a new study. The study raises concern that treatment targets may need to be modified in th ...

Article - News Staff - Apr 30 2011 - 12:16pm

Acetaminophen Overdose May Be Painkiller Confusion

Acetaminophen overdose has become the leading cause of acute liver failure in the U.S. How is that possible, when ingredients are printed clearly on the labels, along with warnings? Acetaminophen's is in more than 600 over-the-counter and prescript ...

Article - News Staff - May 3 2011 - 9:15am

Leukotriene Receptor Antagonists: Asthma Pill More User-friendly Than Inhalers And No Less Effective

Leukotriene receptor antagonists (LTRAs)are easier to use and just as effective as conventional treatment with inhalers, according to a new study led by the University of East Anglia (UEA). Asthma is an increasing problem affecting around 300 million peo ...

Article - News Staff - May 7 2011 - 6:35pm